BioGaia AB (LTS:0GTN) Accounts Payable & Accrued Expense : kr82 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Accounts Payable & Accrued Expense?

BioGaia AB's quarterly accounts payable & accrued expense stayed the same from Jun. 2023 (kr0 Mil) to Sep. 2023 (kr0 Mil) but then increased from Sep. 2023 (kr0 Mil) to Dec. 2023 (kr82 Mil).

BioGaia AB's annual accounts payable & accrued expense increased from Dec. 2021 (kr50 Mil) to Dec. 2022 (kr55 Mil) and increased from Dec. 2022 (kr55 Mil) to Dec. 2023 (kr82 Mil).

BioGaia AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for BioGaia AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Accounts Payable & Accrued Expense Chart

BioGaia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

35.51

51.91

50.17

54.77

82.34

BioGaia AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															54.77	-	-	-	82.34

BioGaia AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BioGaia AB (LTS:0GTN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BIOGY:USA BGLAF:USA BIOG B:Sweden BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB (LTS:0GTN) Headlines

No Headlines